These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12679744)

  • 101. Recommendations for pharmacological management of inpatient aggression in children and adolescents.
    Deshmukh P; Kulkarni G; Barzman D
    Psychiatry (Edgmont); 2010 Feb; 7(2):32-40. PubMed ID: 20376274
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Imaging the neural circuitry and chemical control of aggressive motivation.
    Ferris CF; Stolberg T; Kulkarni P; Murugavel M; Blanchard R; Blanchard DC; Febo M; Brevard M; Simon NG
    BMC Neurosci; 2008 Nov; 9():111. PubMed ID: 19014547
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Pharmacotherapy of aggression in children and adolescents: efficacy and effect size.
    Pappadopulos E; Woolston S; Chait A; Perkins M; Connor DF; Jensen PS
    J Can Acad Child Adolesc Psychiatry; 2006 Feb; 15(1):27-39. PubMed ID: 18392193
    [TBL] [Abstract][Full Text] [Related]  

  • 104. The rewarding effect of aggression is reduced by nucleus accumbens dopamine receptor antagonism in mice.
    Couppis MH; Kennedy CH
    Psychopharmacology (Berl); 2008 Apr; 197(3):449-56. PubMed ID: 18193405
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Heart rate and treatment effect in children with disruptive behavior disorders.
    Stadler C; Grasmann D; Fegert JM; Holtmann M; Poustka F; Schmeck K
    Child Psychiatry Hum Dev; 2008 Sep; 39(3):299-309. PubMed ID: 18058222
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Divalproex sodium for the treatment of PTSD and conduct disordered youth: a pilot randomized controlled clinical trial.
    Steiner H; Saxena KS; Carrion V; Khanzode LA; Silverman M; Chang K
    Child Psychiatry Hum Dev; 2007 Oct; 38(3):183-93. PubMed ID: 17570057
    [TBL] [Abstract][Full Text] [Related]  

  • 107. State and trait emotions in delinquent adolescents.
    Plattner B; Karnik N; Jo B; Hall RE; Schallauer A; Carrion V; Feucht M; Steiner H
    Child Psychiatry Hum Dev; 2007 Aug; 38(2):155-69. PubMed ID: 17417724
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Characterizing aggressive behavior with the Impulsive/Premeditated Aggression Scale among adolescents with conduct disorder.
    Mathias CW; Stanford MS; Marsh DM; Frick PJ; Moeller FG; Swann AC; Dougherty DM
    Psychiatry Res; 2007 Jun; 151(3):231-42. PubMed ID: 17383014
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Treating persistent adolescent aggression.
    Peterson J; Sheldon C
    Curr Treat Options Neurol; 2006 Sep; 8(5):427-38. PubMed ID: 16901382
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Prepubertal bipolar disorder: proper diagnosis should lead to better treatment response.
    Jolin EM; Weller EB; Weller RA
    Curr Psychiatry Rep; 2005 Apr; 7(2):104-11. PubMed ID: 15802086
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Neuropsychiatric symptoms of fragile X syndrome: pathophysiology and pharmacotherapy.
    Tsiouris JA; Brown WT
    CNS Drugs; 2004; 18(11):687-703. PubMed ID: 15330685
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Treatment of aggression in children and adolescents with autism and conduct disorder.
    McDougle CJ; Stigler KA; Posey DJ
    J Clin Psychiatry; 2003; 64 Suppl 4():16-25. PubMed ID: 12672261
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Psychopharmacologic strategies for the treatment of aggression in juveniles.
    Steiner H; Saxena K; Chang K
    CNS Spectr; 2003 Apr; 8(4):298-308. PubMed ID: 12679744
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Juvenile maladaptive aggression: a review of prevention, treatment, and service configuration and a proposed research agenda.
    Connor DF; Carlson GA; Chang KD; Daniolos PT; Ferziger R; Findling RL; Hutchinson JG; Malone RP; Halperin JM; Plattner B; Post RM; Reynolds DL; Rogers KM; Saxena K; Steiner H;
    J Clin Psychiatry; 2006 May; 67(5):808-20. PubMed ID: 16841631
    [TBL] [Abstract][Full Text] [Related]  

  • 115. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 2: antipsychotics and traditional mood stabilizers.
    Pringsheim T; Hirsch L; Gardner D; Gorman DA
    Can J Psychiatry; 2015 Feb; 60(2):52-61. PubMed ID: 25886656
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Psychopharmacology of aggression in children and adolescents with primary neuropsychiatric disorders: a review of current and potentially promising treatment options.
    Nevels RM; Dehon EE; Alexander K; Gontkovsky ST
    Exp Clin Psychopharmacol; 2010 Apr; 18(2):184-201. PubMed ID: 20384430
    [TBL] [Abstract][Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.